Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway.

Mayo MW, Denlinger CE, Broad RM, Yeung F, Reilly ET, Shi Y, Jones DR.

J Biol Chem. 2003 May 23;278(21):18980-9. Epub 2003 Mar 20.

2.

The Akt pathway: molecular targets for anti-cancer drug development.

Mitsiades CS, Mitsiades N, Koutsilieris M.

Curr Cancer Drug Targets. 2004 May;4(3):235-56. Review.

PMID:
15134532
3.

The role of apoptosis in rheumatoid arthritis.

Liu H, Pope RM.

Curr Opin Pharmacol. 2003 Jun;3(3):317-22. Review.

PMID:
12810199
4.

Mechanisms of cell death and survival in multiple myeloma (MM): Therapeutic implications.

Chauhan D, Anderson KC.

Apoptosis. 2003 Aug;8(4):337-43. Review.

PMID:
12815276
5.

The development of phosphatidylinositol ether lipid analogues as inhibitors of the serine/threonine kinase, Akt.

Gills JJ, Dennis PA.

Expert Opin Investig Drugs. 2004 Jul;13(7):787-97. Review.

PMID:
15212619
6.

Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities.

Mathema VB, Koh YS, Thakuri BC, Sillanpää M.

Inflammation. 2012 Apr;35(2):560-5. doi: 10.1007/s10753-011-9346-0. Review.

PMID:
21603970
7.

Mechanisms of resistance to histone deacetylase inhibitors.

Lee JH, Choy ML, Marks PA.

Adv Cancer Res. 2012;116:39-86. doi: 10.1016/B978-0-12-394387-3.00002-1. Review.

PMID:
23088868
8.

The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation.

Barnett SF, Bilodeau MT, Lindsley CW.

Curr Top Med Chem. 2005;5(2):109-25. Review.

PMID:
15853641
9.

Targeting apoptosis pathways in pancreatic cancer.

Arlt A, Müerköster SS, Schäfer H.

Cancer Lett. 2013 May 28;332(2):346-58. doi: 10.1016/j.canlet.2010.10.015. Epub 2010 Nov 13. Review.

PMID:
21078544
10.

Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks.

Pommier Y, Sordet O, Antony S, Hayward RL, Kohn KW.

Oncogene. 2004 Apr 12;23(16):2934-49. Review.

PMID:
15077155
11.

Function and activation of NF-kappa B in the immune system.

Baeuerle PA, Henkel T.

Annu Rev Immunol. 1994;12:141-79. Review.

PMID:
8011280
12.

DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis.

Roos WP, Kaina B.

Cancer Lett. 2013 May 28;332(2):237-48. doi: 10.1016/j.canlet.2012.01.007. Epub 2012 Jan 17. Review.

PMID:
22261329
13.

Transcriptional regulation of the BCL-X gene by NF-kappaB is an element of hypoxic responses in the rat brain.

Glasgow JN, Qiu J, Rassin D, Grafe M, Wood T, Perez-Pol JR.

Neurochem Res. 2001 Jun;26(6):647-59. Review.

PMID:
11519724
14.
15.

Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies.

Solary E, Droin N, Bettaieb A, Corcos L, Dimanche-Boitrel MT, Garrido C.

Leukemia. 2000 Oct;14(10):1833-49. Review.

PMID:
11021759
16.

The strategies of the Theileria parasite: a new twist in host-pathogen interactions.

Dobbelaere DA, Küenzi P.

Curr Opin Immunol. 2004 Aug;16(4):524-30. Review.

PMID:
15245750
17.

Histone deacetylase inhibitors: a patent review (2009 - 2011).

Carafa V, Miceli M, Altucci L, Nebbioso A.

Expert Opin Ther Pat. 2013 Jan;23(1):1-17. doi: 10.1517/13543776.2013.736493. Epub 2012 Oct 25. Review.

PMID:
23094822
18.

Nf-kappa B, chemokine gene transcription and tumour growth.

Richmond A.

Nat Rev Immunol. 2002 Sep;2(9):664-74. Review.

19.

A link between histone deacetylase inhibitors and NF- kappaB signaling.

Trepel J, Birrer MJ.

Cell Cycle. 2003 Sep-Oct;2(5):452-3. Review. No abstract available.

PMID:
12963841
20.

Supplemental Content

Support Center